Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.46 - $40.4 $5.18 Million - $8.55 Million
-211,673 Reduced 55.8%
167,703 $4.46 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $2.54 Million - $3.65 Million
69,713 Added 22.51%
379,376 $15.7 Million
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $4.39 Million - $13.1 Million
309,663 New
309,663 $12.7 Million
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $2.04 Million - $2.98 Million
-31,018 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$73.2 - $107.87 $2.27 Million - $3.35 Million
31,018 New
31,018 $2.55 Million
Q2 2021

Aug 16, 2021

SELL
$60.45 - $84.26 $2.2 Million - $3.07 Million
-36,402 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$58.19 - $91.37 $3.82 Million - $6 Million
-65,614 Reduced 64.32%
36,402 $2.41 Million
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $1.76 Million - $7.39 Million
86,956 Added 577.4%
102,016 $8.66 Million
Q3 2020

Nov 16, 2020

SELL
$22.99 - $36.34 $465,202 - $735,339
-20,235 Reduced 57.33%
15,060 $356,000
Q2 2020

Aug 14, 2020

BUY
$29.88 - $56.74 $716,761 - $1.36 Million
23,988 Added 212.15%
35,295 $1.18 Million
Q1 2020

May 15, 2020

BUY
$33.0 - $54.5 $33,759 - $55,753
1,023 Added 9.95%
11,307 $456,000
Q4 2019

Feb 14, 2020

BUY
$15.39 - $44.38 $158,270 - $456,403
10,284 New
10,284 $423,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.33B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.